The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 03, 2022

Filed:

Dec. 15, 2016
Applicant:

Illumina, Inc., San Diego, CA (US);

Inventors:

Jonathan Toung, San Diego, CA (US);

Li Liu, San Diego, CA (US);

Min-Jui Richard Shen, Rancho Santa Fe, CA (US);

Ruoyu Zhang, Ithaca, NY (US);

Assignee:

Illumina, Inc., San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/6886 (2018.01); G16B 25/10 (2019.01); G16B 20/10 (2019.01); G16H 50/30 (2018.01); G16B 40/00 (2019.01); G16B 99/00 (2019.01);
U.S. Cl.
CPC ...
C12Q 1/6886 (2013.01); G16B 20/10 (2019.02); G16B 25/10 (2019.02); G16B 40/00 (2019.02); G16B 99/00 (2019.02); G16H 50/30 (2018.01); C12Q 2600/154 (2013.01);
Abstract

Provided herein is a method for distinguishing an aberrant methylation level for DNA from a first cell type, including steps of (a) providing a test data set that includes (i) methylation states for a plurality of sites from test genomic DNA from at least one test organism, and (ii) coverage at each of the sites for detection of the methylation states; (b) providing methylation states for the plurality of sites in reference genomic DNA from one or more reference individual organisms, (c) determining, for each of the sites, the methylation difference between the test genomic DNA and the reference genomic DNA, thereby providing a normalized methylation difference for each site; and (d) weighting the normalized methylation difference for each site by the coverage at each of the sites, thereby determining an aggregate coverage-weighted normalized methylation difference score. Also provided herein are sensitive methods for using genomic DNA methylation levels to distinguish cancer cells from normal cells and to classify different cancer types according to their tissues of origin.


Find Patent Forward Citations

Loading…